Bhopal : Due to various diseases and lifestyle and professional reasons, the pain in different parts of the body is now possible by remedies that are far less difficult. For discussions about world-class innovative techniques coming in this direction,a seminar was held on 14th of February in J.K. hospital on the topic of minimally invasive technology for pain relieving.
Doctor Kulvir Singh from Canada discusses the modern technology of pain relief
Expert from Canada Dr. Kulvir Singh Billing and local specialist Dr. Rupesh Jain addressed the seminar. The seminar was specially based on Trigeminal neuralgia disease. Dr. Jain also informed that the treatment of pain with minimal invasive technique of pain relief is now possible in Bhopal. In this disease, there is a pain like current in the patient’s body, and creates pressure on the fifth number of brain nerve that is called Trigeminal nerves.
Treatment of this disease is done by medicines, radio frequency ablation or surgery according to its condition. He further said that in addition to Trigeminal neuralgia, this seminar also discussed about waist pain, knee pain and Saitika.
In this seminar two patients who are recovering from Trigeminal techniques were also introduced to the media.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022